Viewing Study NCT03512405


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-03-02 @ 3:48 PM
Study NCT ID: NCT03512405
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-30
First Post: 2018-04-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia
Sponsor: City of Hope Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module